Strides Pharma Trading Ex-Dividend Today, July 31, 2026: Announces Final Dividend Of ₹5 Per Share

Strides Pharma has announced a final dividend of ₹5 per equity share for the financial year ended March 31, 2026. Each equity share has a face value of ₹10, making the dividend equivalent to a 50% payout on the face value.
The dividend was recommended by the company's Board of Directors at its meeting held on May 18, 2026, and is subject to approval by shareholders at the Annual General Meeting (AGM).
Strides Pharma Ex-Dividend and Record Date
The ex-dividend date and record date for the final dividend are both July 31, 2026.
Investors who held Strides Pharma shares at the close of business on the record date will be eligible to receive the dividend. The payment is expected to be made after shareholder approval at the AGM and will generally be credited within 30 days.
Dividend Details
| Particulars | Details |
| Dividend per Share | ₹5.00 |
| Face Value | ₹10 per share |
| Dividend Type | Final Dividend |
| Ex-Dividend Date | July 31, 2026 |
| Record Date | July 31, 2026 |
| Payment Date | After AGM approval |
| Dividend Yield* | Around 0.47% |
Dividend Trend Over the Years
Strides Pharma has steadily increased its dividend payout over the past 3 financial years.
| Financial Year | Dividend Per Share |
| FY26 | ₹5.00 |
| FY25 | ₹4.00 |
| FY24 | ₹2.50 |
The rising dividend reflects the company's focus on rewarding shareholders while maintaining a healthy financial position.
Financial Performance in FY26
The dividend announcement follows a strong financial year for the company.
For the year ended March 31, 2026, Strides Pharma reported:
- Consolidated revenue: ₹4,858.68 crore
- Consolidated net profit: ₹574.05 crore
- Basic earnings per share (EPS): ₹60.34
The company has also shown a significant improvement in profitability, moving from a net loss of ₹363.44 crore in FY22 to a net profit of ₹574.05 crore in FY26.
Read More: Best Gold Stocks in July 2026 Based on 5‑Year CAGR: Sky Gold and Diamonds, Laxmi Goldorna House and More!
Strides Pharma Share Price Movement
On July 31, 2026, Strides Pharma Science share price was trading at ₹1,066.10, down 0.62% or ₹6.70 in the intraday session. The stock opened at ₹1,073.60 and touched an intraday high of ₹1,084.40 and a low of ₹1,060.10.
Conclusion
Strides Pharma's decision to increase its final dividend to ₹5 per share reflects its improved financial performance and continued commitment to rewarding shareholders.
Investors interested in dividend-paying stocks can open a demat account to conveniently invest and trade in the stock market.
For daily market updates and regular stock market news in Hindi, stay tuned to Angel One's share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all related documents carefully before investing.
Turn insights into action - Open Free Demat Account with Angel One and start investing instantly.
Published on: Jul 31, 2026, 12:40 PM IST

Kusum Kumari
Kusum Kumari is a Content Writer with 4 years of experience in simplifying financial market concepts. Currently crafting insightful content at Angel One, She specialise in breaking down complex topics into easy-to-understand pieces, blending expertise in market fundamentals and technical analysis.
Know More- JTL Industries Share Price in Focus; Subsidiary to Double Narrow-Width HR Coil Capacity
- Caplin Point Laboratories Shares in Focus; Announces Completion of Unannounced US FDA Inspection at Facility
- Insolation Energy Share Price in Focus; Wins 99 MW Solar Projects From MSEDCL
- Blue Cloud Softech Solutions Share Price Rises Nearly 5%, Begins Execution of $150 Million SpaceX International Agreement
- TVS Supply Chain Solutions Share Price Surges 7%; Signs MoU with Japan’s Sankyu


